Tamoxifen exposure in relation to gastric adenocarcinoma development

European Journal of Cancer

Volumn 44, Issue 7, 2008, Pages 1007-1014

  Chandanos, Evangelos ^a   Lindblad, Mats ^a   Rubio, Carlos A ^b   Jia, Chongqi ^c   Warner, Margaret ^a   Gustafsson, Jan Åke ^a   Lagergren, Jesper ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Anti oestrogen; Breast; ER cx; Histology; Neoplasm; Oestrogen; Stomach

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RISK FACTORS; STOMACH; STOMACH NEOPLASMS; SWEDEN; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 43049131409     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.049     Document Type: Article

References (35)

1. Chandanos E., Lindblad M., Jia C., Rubio C.A., Ye W., and Lagergren J. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden. Br J Cancer 95 1 (2006) 118-122
2. Lindblad M., Garcia Rodriguez L.A., Chandanos E., and Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 94 1 (2006) 136-141
3. Lindblad M., Ye W., Rubio C., and Lagergren J. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2203-2207
4. Frise S., Kreiger N., Gallinger S., Tomlinson G., and Cotterchio M. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the Canadian national enhanced cancer surveillance system. Ann Epidemiol 16 12 (2006) 908-916
5. Freedman N.D., Chow W.H., Gao Y.T., et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut (2007)
6. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
7. Sipponen P., and Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5 4 (2002) 213-219
8. Andersson M., Storm H.H., and Mouridsen H.T. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83 14 (1991) 1013-1017
9. Curtis R.E., Boice Jr. J.D., Shriner D.A., Hankey B.F., and Fraumeni Jr. J.F. Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 88 12 (1996) 832-834
10. Matsuyama Y., Tominaga T., Nomura Y., et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 11 12 (2000) 1537-1543
11. Rutqvist L.E., Johansson H., Signomklao T., Johansson U., Fornander T., and Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87 9 (1995) 645-651
12. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., and Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 231 4742 (1986) 1150-1154
13. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93 12 (1996) 5925-5930
14. Matsuyama S., Ohkura Y., Eguchi H., et al. Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol 128 6 (2002) 319-324
15. Tokunaga A., Kojima N., Andoh T., et al. Hormone receptors in gastric cancer. Eur J Cancer Clin Oncol 19 5 (1983) 687-689
16. Moore J.T., McKee D.D., Slentz-Kesler K., et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 247 1 (1998) 75-78
17. Ekstrom A.M., Signorello L.B., Hansson L.E., Bergstrom R., Lindgren A., and Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 91 9 (1999) 786-790
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
19. Ming S.C. Gastric carcinoma. A pathobiological classification. Cancer 39 6 (1977) 2475-2485
20. Palmieri C., Lam E.W., Mansi J., et al. The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival. Clin Cancer Res 10 7 (2004) 2421-2428
21. Wang H.H., Mangano M.M., and Antonioli D.A. Evaluation of T-lymphocytes in esophageal mucosal biopsies. Mod Pathol 7 1 (1994) 55-58
22. Heldring N., Pike A., Andersson S., et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87 3 (2007) 905-931
23. Matsui M., Kojima O., Uehara Y., and Takahashi T. Characterization of estrogen receptor in human gastric cancer. Cancer 68 2 (1991) 305-308
24. Crew K.D., and Neugut A.I. Epidemiology of gastric cancer. World J Gastroenterol 12 3 (2006) 354-362
25. Ekstrom A.M., Eriksson M., Hansson L.E., et al. Occupational exposures and risk of gastric cancer in a population-based case-control study. Cancer Res 59 23 (1999) 5932-5937
26. Hansson L.R., Engstrand L., Nyren O., and Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 109 3 (1995) 885-888
27. Lunet N., Valbuena C., Vieira A.L., et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev 16 4 (2007) 312-327
28. Wang C., Yuan Y., and Hunt R.H. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 102 8 (2007) 1789-1798
29. Ye W., Ekstrom A.M., Hansson L.E., Bergstrom R., and Nyren O. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer 83 2 (1999) 223-229
30. Osborne C.K. Tamoxifen in the treatment of breast cancer. New Engl J Med 339 22 (1998) 1609-1618
31. Taupin D., and Podolsky D.K. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4 9 (2003) 721-732
32. Shi S.Q., Cai J.T., and Yang J.M. Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer. World J Gastroenterol 12 19 (2006) 3119-3122
33. Campbell-Thompson M.L. Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun 240 2 (1997) 478-483
34. Wu C.W., Lui W.Y., P'Eng F.K., and Chi C.W. Hormonal therapy for stomach cancer. Med Hypotheses 39 2 (1992) 137-139
35. Wilking N., Isaksson E., and von Schoultz E. Tamoxifen and secondary tumours. An update. Drug Saf 16 2 (1997) 104-117